XML 14 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2021
Cash flows from operating activities:          
Net loss $ (2,856,834) $ (1,656,397) $ (4,452,203) $ (375,188)  
Non-controlling interest (54,168) (361,519)  
Adjustments to reconcile net loss to cash flows from operating activities:          
Excess derivative expense     1,118,990 316,261  
Loss on settlement 5,000 80,000  
Gain on loss of control of VIE (313,928) (313,928)  
Return on EB5 Investment     500,000  
Amortization of debt discount 24,071 1,031,379 156,651 1,845,925  
Stock based compensation     124,000 66,000  
Change in fair value of derivative liability     65,073 (3,992,108)  
Change in exercise of warrant     (14,637) (70,389)  
Depreciation     98,238 44,684  
Amortization of intangible assets     2,016 700  
Equity method investment loss     60,747  
Unrealized loss on securities 215,862 857,979  
Changes in assets and liabilities:          
Accounts receivable     (271,911) 122,971  
Inventory     (202,338) (83,253)  
Prepayment, deposits and other receivables     (2,495) (855,878)  
Other payables     (131,502) 404,993  
Accounts payable and accrued liabilities     362,867 465,435  
Customer deposits     150,915 137,313  
Unearned revenue     3,909  
Right of use assets     118,795 119,483  
Lease liability     (121,983) (118,078)  
Investment to Indigo Dye     (564,818)  
Interest Payable     43,121 98,780  
Net cash used in operating activities     (2,399,196) (2,167,187)  
Cash flows from investing activities:          
Purchase of fixed assets     (1,213,278)  
Net cash used in investing activities     (1,213,278)  
Cash flows from financing activities:          
Proceeds from shares issuance     430,680  
Distributions of capital to noncontrolling minority      
Loan receivable     (13,911)  
Loan receivable - related parties     38,044  
Proceeds (Repayment) from(to) notes payable, net     (110,120)  
Proceeds (Repayment) from(to) note payable - related parties, net     (15,427)  
Proceeds from advanced shares issuance     500,000  
Proceeds (Repayment) from(to) loans payable, net     949,546 271,929  
Proceeds (Repayment) from(to) loans payable - related parties, net     524,226 540,281  
Proceeds from convertible notes     1,804,900  
Repayment of convertible notes     (227,700)  
Reduction of cash due to Indigo deconsolidation     (326,811)  
Net cash provided by financing activities     2,278,905 2,086,732  
Net decrease in cash     (1,333,569) (80,454)  
Cash paid during the period for:          
Cash, beginning of period     1,396,944 441,004 $ 441,004
Cash, end of period $ 63,375 $ 360,550 63,375 360,550 $ 1,396,944
Cash paid interest      
Supplemental disclosure of non-cash financing activities —          
Shares issued for conversion of convertible debt     535,269 1,594,338  
Reduction in derivative liability due to conversion     769,071 2,336,779  
Debt discount related to convertible debt     $ 2,010,717